Cartesian Therapeutics (RNAC) Receivables (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Receivables of $261000.0 for Q1 2026, down 85.21% year-over-year from $1.8 million in Q1 2025, and down 76.59% quarter-over-quarter from $1.1 million in Q4 2025.
Cartesian Therapeutics (RNAC) Receivables (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Receivables data on file, last reported at $261000.0 in Q1 2026.
- Receivables for Q1 2026 came in at $261000.0, down 85.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $261000.0 (down 85.21% YoY), and the FY2025 annual result was $1.1 million, up 27.87% from the prior year.
- Receivables retreated to $261000.0 in Q1 2026 per RNAC's latest filing, from $1.1 million in the prior quarter.
- Over five years, Receivables peaked at $35.5 million in Q2 2024 and troughed at $261000.0 in Q1 2026.
- A 5-year average of $7.6 million and a median of $6.4 million in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2025: Receivables soared 451.41% in 2024, then slumped 99.0% in 2025.
- A 5-year view of Receivables shows it stood at $9.8 million in 2022, then dropped by 9.29% to $8.9 million in 2023, then sank by 90.15% to $872000.0 in 2024, then grew by 27.87% to $1.1 million in 2025, then tumbled by 76.59% to $261000.0 in 2026.
- Business Quant data shows RNAC's Receivables at $261000.0 in Q1 2026, $1.1 million in Q4 2025, and $722000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | 261,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 261,000.00 |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 722,000.00 |
| Jun 30, 2025 | 354,000.00 |
| Mar 31, 2025 | 1.77 Mn |
| Dec 31, 2024 | 872,000.00 |
| Sep 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 35.51 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Dec 31, 2023 | 8.85 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Jun 30, 2023 | 6.44 Mn |
| Mar 31, 2023 | 8.68 Mn |
| Dec 31, 2022 | 9.76 Mn |
| Sep 30, 2022 | 6.93 Mn |
| Jun 30, 2022 | 23.99 Mn |
| Mar 31, 2022 | 7.15 Mn |
| Dec 31, 2021 | 9.91 Mn |
| Sep 30, 2021 | 8.32 Mn |
| Jun 30, 2021 | 8.56 Mn |